Vitamin D and Longevity: Separating Genuine Benefit from Wishful Thinking
Vitamin D is the most commonly supplemented micronutrient in the world and one of the most scientifically contested. Observational data linking low vitamin D to almost every disease known to medicine generated enormous enthusiasm. But RCTs have repeatedly failed to confirm these associations as causal. Here is the honest accounting.
- Vitamin D insufficiency affects 40 to 50 percent of the US population and is associated with elevated risk of virtually every age-related disease in observational studies. The breadth of these associations is both compelling and, as it turns out, partly misleading.
- The VITAL trial - 25,871 participants over 5.3 years - found no significant reduction in cardiovascular disease or cancer incidence with 2,000 IU/day of vitamin D3. However, pre-specified analyses found significant cancer mortality reduction (25 percent) and lower rates of autoimmune disease in supplemented participants.
- The most likely explanation for the observational-RCT discrepancy is reverse causation: low vitamin D status is a consequence of the same poor health behaviors that cause the diseases with which it is associated.
- Vitamin D has well-established roles in calcium absorption, bone metabolism, immune function, and muscle function. The evidence for these effects is mechanistic, consistent, and not seriously contested.
- Test, do not guess. Supplement to achieve a 25-OH vitamin D level of 40 to 60 ng/mL if below that threshold. The required dose varies widely between individuals based on sun exposure, body weight, skin pigmentation, and genetics.
The vitamin D story is a cautionary tale in nutritional epidemiology. Observational studies have linked low 25-OH vitamin D levels to seemingly every major disease - cardiovascular disease, cancer, diabetes, multiple sclerosis, depression, Alzheimer's disease, and all-cause mortality. The biological plausibility is strong - vitamin D receptors are expressed in virtually every tissue, and active vitamin D regulates hundreds of genes involved in immune function and inflammatory signaling.1
The problem is that observational associations, however numerous and biologically plausible, can be explained by reverse causation and confounding. Sick, sedentary, and obese people spend less time outdoors, eat less vitamin D-rich food, and have reduced synthesis. They also have higher rates of every chronic disease. The association between low vitamin D and disease may therefore primarily reflect that being sick causes low vitamin D, not the reverse.
The VITAL Trial: The Definitive RCT
The VITAL trial enrolled 25,871 US adults randomized to 2,000 IU/day of vitamin D3 plus omega-3 versus placebo, with 5.3 years of follow-up. Primary results: no significant reduction in cardiovascular disease (HR 0.97) or cancer (HR 0.96). This was a well-powered negative result that substantially deflated the observational enthusiasm.2 However, pre-specified secondary analyses showed cancer mortality significantly reduced by 25 percent, and autoimmune disease incidence reduced by 22 percent. A meta-analysis of VITAL and other large RCTs found that vitamin D significantly reduced all-cause mortality, driven primarily by cancer mortality.3
What Vitamin D Actually Does: The Established Biology
Calcium and bone metabolism is the most robustly established function. Vitamin D is essential for intestinal calcium absorption - without adequate vitamin D, only 10 to 15 percent of dietary calcium is absorbed versus 30 to 40 percent with sufficiency. Supplementation reduces hip fracture risk in elderly populations in RCTs, particularly when combined with calcium.4 Immune function is the second well-established domain. Vitamin D receptors on virtually all immune cells modulate both innate and adaptive immunity. A meta-analysis of 25 RCTs found that supplementation significantly reduced risk of acute respiratory tract infections, with the greatest effect in those with baseline deficiency.5
Optimal Vitamin D Levels
| 25-OH Vitamin D Level | Status | Recommendation |
|---|---|---|
| <20 ng/mL | Deficiency | Supplement aggressively (2,000-4,000 IU/day) |
| 20-30 ng/mL | Insufficiency | Supplement (1,000-2,000 IU/day) |
| 40-60 ng/mL | Optimal (longevity target) | Maintain this range |
| >80 ng/mL | Potentially excessive | Reduce supplementation |
Take vitamin D3 (cholecalciferol, more effective than D2) with a fatty meal for optimal absorption. Co-supplement with vitamin K2 (MK-7 form, 100 to 200 mcg/day) when taking vitamin D3 above 2,000 IU - vitamin K2 directs calcium into bone rather than arterial walls. Retest 25-OH vitamin D 3 months after starting or changing dose.
References
- 1Holick MF. "Vitamin D deficiency." NEJM. 2007;357(3):266-281. [PubMed]
- 2Manson JE, et al. "Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (VITAL)." NEJM. 2019;380(1):33-44. [PubMed]
- 3Scragg R. "Overview of results from the Vitamin D Assessment (ViDA) study." Journal of Endocrinological Investigation. 2019. [PubMed]
- 4Bischoff-Ferrari HA, et al. "Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials." JAMA. 2005. [PubMed]
- 5Martineau AR, et al. "Vitamin D supplementation to prevent acute respiratory tract infections." BMJ. 2017;356:i6583. [PubMed]